# Cheerland

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cheerland

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.clbiomed.com
- Latest round: Series B (Oct 30, 2023)
- Investors on record: 1

## About

Based in Shenzhen, China, and founded in 2016, Cheerland is a biomedical company focusing on biologics contract development and manufacturing. It has set up subsidiaries and medical testing laboratories in Shenzhen, Beijing, Shanghai, Chengdu, and other cities, as well as investment and business development departments in the United States and Europe. In June 2023, it completed series B funding. The company's founder and chairman of the board, Ruyin Liu has over 20 years of experience in capital investment and business operations.

The company is committed to providing pharmaceutical companies with CDMO(Contract Development and Manufacturing Organization) services for clinical samples and the commercialization of biologics. It also engaged in molecular testing business, medical services, and project investment covering prevention, diagnosis, treatment, etc.

The company will use the funds for the construction of biopharmaceutical development and production bases in Shenzhen and Shanghai.

## Funding rounds

- Series B, Oct 30, 2023 — China International Capital Corporation
- Series A, Jun 7, 2021 — China International Capital Corporation

## Investors

- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series A, Series B